dronabinol and am 630
dronabinol has been researched along with am 630 in 24 studies
Research
Studies (24)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (37.50) | 29.6817 |
| 2010's | 15 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Allarà, M; Di Marzo, V; Escobar, R; Faúndez, M; Iturriaga-Vásquez, P; Mella-Raipán, J; Palmieri, V; Pessoa-Mahana, CD; Pessoa-Mahana, H; Romero-Parra, J; Torres, MJ | 1 |
| Cheng, J; McCorvy, JD; Tan, L; Yan, W | 1 |
| Bánki, L; Deli, MA; Dvorácskó, S; Horváth, G; Kékesi, G; Keresztes, A; Macedonio, G; Mollica, A; Pieretti, S; Stefanucci, A; Tömböly, C; Tuboly, G; Walter, FR; Zádor, F | 1 |
| Fowler, CJ; Jacobsson, SO; Nilsson, O | 1 |
| Kendall, DA; Ralevic, V; Wilkinson, JD | 1 |
| Järbe, TU; Li, C; Makriyannis, A; Vadivel, SK | 1 |
| Araújo, JR; Azevedo, I; Gonçalves, P; Martel, F | 1 |
| Ballesteros, I; Chancellor, MB; Coyle, CH; de Miguel, F; Hayn, MH; Tyagi, P; Tyagi, S; Yoshimura, N | 1 |
| Araújo, JR; Gonçalves, P; Martel, F | 1 |
| Fuchs, D; Jenny, M; Pirich, E; Santer, E; Schennach, H | 1 |
| Challapalli, SC; Smith, PJ; Zhang, F | 1 |
| Börner, C; Höllt, V; Kraus, J; Schraven, B; Smida, M | 1 |
| Touriño, C; Valverde, O; Zimmer, A | 1 |
| Brett, RR; Kane, KA; Kennedy, S; Mair, KM; Pyne, NJ; Pyne, S; Robinson, E | 1 |
| Bombolewski, R; Debinski, A; Filipek, S; Ghoshdastider, U; Jozwiak, K; Kolinski, M; Latek, D; Plazinska, A | 1 |
| Gomez, O; Le, M; Molina-Holgado, E; Molina-Holgado, F; Sanchez-Caro, C; Sanchez-Rodriguez, A | 1 |
| Bolognini, D; Cascio, MG; Parolaro, D; Pertwee, RG | 1 |
| Hegde, VL; Lombard, C; Nagarkatti, M; Nagarkatti, PS | 1 |
| Cornett, BL; Deng, L; Guindon, J; Hohmann, AG; Mackie, K; Makriyannis, A | 1 |
| Keller, A; Raver, SM | 1 |
| Calik, MW; Carley, DW | 2 |
| Bagüés, A; Martín, MI; Sánchez-Robles, EM | 1 |
| Fantegrossi, WE; Tai, S | 1 |
Reviews
2 review(s) available for dronabinol and am 630
| Article | Year |
|---|---|
Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential.
Topics: Animals; Drug Discovery; Humans; Ligands; Receptors, G-Protein-Coupled; Signal Transduction; Structure-Activity Relationship | 2018 |
Pharmacological and Toxicological Effects of Synthetic Cannabinoids and Their Metabolites.
Topics: Adamantane; Animals; Benzoxazines; Cannabinoid Receptor Agonists; Cannabinoids; Cytochrome P-450 Enzyme System; Dronabinol; Drug Interactions; Humans; Indazoles; Indoles; Morpholines; Naphthalenes; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2017 |
Other Studies
22 other study(ies) available for dronabinol and am 630
| Article | Year |
|---|---|
Synthesis, binding assays, cytotoxic activity and docking studies of benzimidazole and benzothiophene derivatives with selective affinity for the CB2 cannabinoid receptor.
Topics: Antineoplastic Agents; Benzimidazoles; Cell Line, Tumor; Cell Survival; Chemistry Techniques, Synthetic; Drug Design; Humans; Molecular Docking Simulation; Protein Binding; Protein Conformation; Receptor, Cannabinoid, CB2; Thiophenes | 2016 |
Preparation of bivalent agonists for targeting the mu opioid and cannabinoid receptors.
Topics: Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Enkephalins; Indoles; Mice; Molecular Structure; Naphthalenes; Oxycodone; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Opioid, mu; Structure-Activity Relationship | 2019 |
The cannabinoid agonist WIN 55,212-2 inhibits TNF-alpha-induced neutrophil transmigration across ECV304 cells.
Topics: Analysis of Variance; Arachidonic Acids; Benzoxazines; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cell Line; Cell Movement; Chemotaxis; Cyclohexanols; Dose-Response Relationship, Drug; Dronabinol; Endocannabinoids; Endothelial Cells; Flow Cytometry; Humans; Indoles; Interleukin-8; L-Lactate Dehydrogenase; Morpholines; Naphthalenes; Neutrophils; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptors, Cannabinoid; Receptors, Interleukin-8A; Receptors, Interleukin-8B; Thapsigargin; Tumor Necrosis Factor-alpha | 2006 |
Delta 9-tetrahydrocannabinol inhibits electrically-evoked CGRP release and capsaicin-sensitive sensory neurogenic vasodilatation in the rat mesenteric arterial bed.
Topics: Animals; Calcitonin Gene-Related Peptide; Capsaicin; Dose-Response Relationship, Drug; Dronabinol; Electric Stimulation; Indoles; Male; Mesenteric Arteries; Methoxamine; Neurons, Afferent; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Ruthenium Red; Time Factors; Vasodilation | 2007 |
Discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats.
Topics: Animals; Arachidonic Acids; Avoidance Learning; Camphanes; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Drinking; Dronabinol; Hallucinogens; Indoles; Injections, Intraperitoneal; Lithium Chloride; Male; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Taste | 2008 |
Lack of a significant effect of cannabinoids upon the uptake of 2-deoxy-D-glucose by Caco-2 cells.
Topics: Arachidonic Acids; Caco-2 Cells; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cannabinoids; Cyclohexanols; Deoxyglucose; Dronabinol; Endocannabinoids; Humans; Indoles; Intestinal Absorption; Piperidines; Polyunsaturated Alkamides; Pyrazoles | 2008 |
Functional and immunohistochemical characterization of CB1 and CB2 receptors in rat bladder.
Topics: Animals; Calcitonin Gene-Related Peptide; Dronabinol; Female; Indoles; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Tissue Culture Techniques; Urinary Bladder | 2008 |
Effect of cannabinoids upon the uptake of folic acid by BeWo cells.
Topics: Arachidonic Acids; Carrier Proteins; Cell Culture Techniques; Cell Line, Tumor; Cyclohexanols; Dronabinol; Drug Administration Schedule; Endocannabinoids; Female; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Hydrogen-Ion Concentration; Indoles; Membrane Transport Proteins; Piperidines; Placenta; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Cell Surface | 2009 |
Delta9-tetrahydrocannabinol and cannabidiol modulate mitogen-induced tryptophan degradation and neopterin formation in peripheral blood mononuclear cells in vitro.
Topics: Cannabidiol; Cannabinoid Receptor Antagonists; Cell Proliferation; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Gene Expression Regulation; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Indoles; Interferon-alpha; Kynurenine; Leukocytes, Mononuclear; Lipopolysaccharides; Mitogens; Morpholines; Neopterin; Pyrazoles; Statistics, Nonparametric; Tryptophan | 2009 |
Cannabinoid CB(1) receptor activation stimulates neurite outgrowth and inhibits capsaicin-induced Ca(2+) influx in an in vitro model of diabetic neuropathy.
Topics: Animals; Calcium; Capsaicin; Diabetic Neuropathies; Dose-Response Relationship, Drug; Dronabinol; Glucose; Hyperglycemia; Indoles; Nerve Growth Factor; Neurites; Neurogenesis; Neurons; Neuroprotective Agents; PC12 Cells; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; RNA, Messenger; Sensory System Agents | 2009 |
Cannabinoid receptor type 1- and 2-mediated increase in cyclic AMP inhibits T cell receptor-triggered signaling.
Topics: Arachidonic Acids; Cannabinoids; Cell Proliferation; CSK Tyrosine-Protein Kinase; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dronabinol; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; Indoles; Interleukin-2; Jurkat Cells; Lymphocyte Activation; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Morpholines; Multiple Sclerosis; Phosphorylation; Protein-Tyrosine Kinases; Psychotropic Drugs; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Antigen, T-Cell; Signal Transduction; src-Family Kinases; T-Lymphocytes | 2009 |
THC Prevents MDMA Neurotoxicity in Mice.
Topics: Animals; Astrocytes; Body Temperature; Dronabinol; Fever; Hallucinogens; Indoles; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes; Piperidines; Psychotropic Drugs; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Temperature | 2010 |
Interaction between anandamide and sphingosine-1-phosphate in mediating vasorelaxation in rat coronary artery.
Topics: Animals; Arachidonic Acids; Calcium Channel Blockers; Cardiovascular Agents; Cell Line; Coronary Vessels; Dronabinol; Endocannabinoids; Humans; Indoles; Indomethacin; Lysophospholipids; Male; Polyunsaturated Alkamides; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB2; Sphingosine; Vasodilation | 2010 |
Modeling of ligand binding to G protein coupled receptors: cannabinoid CB1, CB2 and adrenergic β 2 AR.
Topics: Amino Acid Motifs; Arachidonic Acids; Binding Sites; Dronabinol; Endocannabinoids; Fenoterol; Humans; Hydrogen Bonding; Indoles; Ligands; Molecular Dynamics Simulation; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Adrenergic, beta-2; Stereoisomerism; Thermodynamics | 2011 |
Cannabinoid receptor agonists modulate oligodendrocyte differentiation by activating PI3K/Akt and the mammalian target of rapamycin (mTOR) pathways.
Topics: Animals; Arachidonic Acids; Cannabinoids; Cell Differentiation; Cells, Cultured; Chromones; Dronabinol; Enzyme Activators; Indoles; Morpholines; Myelin Proteins; Oligodendroglia; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Signal Transduction; Sirolimus; Stem Cells; TOR Serine-Threonine Kinases | 2011 |
AM630 behaves as a protean ligand at the human cannabinoid CB2 receptor.
Topics: Animals; Benzoxazines; Camphanes; Cannabinoids; CHO Cells; Cricetinae; Cricetulus; Cyclohexanols; Dronabinol; Humans; Indoles; Ligands; Morpholines; Naphthalenes; Pyrazoles; Radioligand Assay; Receptor, Cannabinoid, CB2 | 2012 |
Perinatal exposure to Δ9-tetrahydrocannabinol triggers profound defects in T cell differentiation and function in fetal and postnatal stages of life, including decreased responsiveness to HIV antigens.
Topics: Animals; Apoptosis; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Caspases; Dronabinol; Female; Fetus; HIV Antibodies; HIV Antigens; HIV-1; Indoles; Lymphocyte Activation; Lymphopoiesis; Marijuana Smoking; Mice; Mice, Inbred C57BL; Piperidines; Pregnancy; Prenatal Exposure Delayed Effects; Psychotropic Drugs; Pyrazoles; Receptors, Cannabinoid; Rimonabant; T-Lymphocytes; Thymocytes; Thymus Gland | 2011 |
Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Chemokine CCL2; Chromones; Disease Models, Animal; Dronabinol; Female; Hyperalgesia; Indoles; Male; Mice, Inbred C57BL; Mice, Knockout; Paclitaxel; Random Allocation; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; RNA, Messenger; Spinal Cord; Tumor Necrosis Factor-alpha | 2015 |
Permanent suppression of cortical oscillations in mice after adolescent exposure to cannabinoids: receptor mechanisms.
Topics: Animals; Benzoxazines; Cannabinoid Receptor Modulators; Dronabinol; Indoles; Male; Mice; Morpholines; Naphthalenes; Piperidines; Prefrontal Cortex; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Somatosensory Cortex; Tissue Culture Techniques | 2014 |
Cannabinoid type 1 and type 2 receptor antagonists prevent attenuation of serotonin-induced reflex apneas by dronabinol in Sprague-Dawley rats.
Topics: Animals; Cannabinoid Receptor Agonists; Dronabinol; Electromyography; Femoral Vein; Indoles; Male; Nodose Ganglion; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Serotonin; Sleep Apnea, Obstructive; Treatment Outcome | 2014 |
Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain.
Topics: Analgesics; Animals; Cannabinoid Receptor Agonists; Dronabinol; Indoles; Injections, Intramuscular; Injections, Intraperitoneal; Male; Masseter Muscle; Muscle, Skeletal; Myalgia; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid | 2014 |
Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley Rats.
Topics: Animals; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Disease Models, Animal; Dronabinol; Electroencephalography; Electromyography; Indoles; Male; Piperidines; Polysomnography; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Respiration; Sleep; Sleep Apnea, Central; Sleep, REM; Vagus Nerve | 2017 |